Shechter Alon, Vaturi Mordehay, Kaewkes Danon, Koren Ofir, Koseki Keita, Solanki Aum, Natanzon Sharon Shalom, Patel Vivek, Skaf Sabah, Makar Moody, Chakravarty Tarun, Makkar Raj R, Siegel Robert J
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California; Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Am Soc Echocardiogr. 2023 Apr;36(4):391-401.e19. doi: 10.1016/j.echo.2022.12.026. Epub 2023 Jan 16.
A surrogate of right ventricular-pulmonary arterial coupling, the ratio of tricuspid annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (PASP) has been associated with outcomes across a wide range of cardiac pathologies and interventions. The aim of this study was to assess the prognostic significance of baseline TAPSE/PASP ratio in patients undergoing mitral transcatheter edge-to-edge repair.
This was a single-center, retrospective analysis encompassing 448 days (interquartile range, 86-958 days) of follow-up after 707 consecutive isolated, first-time mitral transcatheter edge-to-edge repair procedures. Stratified by the cohort's median TAPSE/PASP ratio of 0.37 mm/mm Hg, eligible cases were examined for the occurrence of all-cause mortality and heart failure hospitalization.
Patients with low TAPSE/PASP ratios exhibited a greater prevalence of functional mitral regurgitation, a higher burden of comorbidities, and worse clinical and echocardiographic indices of cardiac function, as well as an attenuated rate of technical success. After the procedure, they experienced similar 1-month and 1-year improvement in mitral regurgitation grade and functional status but higher rates of death, heart failure hospitalizations, and the composite of both at all time points explored (1 year, 15.3% vs 7.6%, 20.7% vs 10.2%, and 32.3% vs 16.1%, respectively; P < .001 for all). Lower TAPSE/PASP ratio was independently associated with a higher risk for the 1-year combined end point of death or heart failure hospitalizations (hazard ratio, 2.84; 95% CI, 1.09-7.43; P = .033). A novel TAPSE/PASP-MitraScore risk model showed a better discriminative property than currently validated scores. Subgroup analysis produced similarly significant observations solely in patients with functional mitral regurgitation (n = 383 [54.2%]), which remained when using subgroup-specific medians of the baseline TAPSE/PASP ratio.
A low TAPSE/PASP ratio before mitral transcatheter edge-to-edge repair identifies higher risk patients and predicts a less favorable outcome after the procedure.
作为右心室-肺动脉耦合的替代指标,三尖瓣环平面收缩期位移(TAPSE)与肺动脉收缩压(PASP)的比值已与多种心脏疾病和干预措施的预后相关。本研究的目的是评估经导管二尖瓣缘对缘修复患者基线TAPSE/PASP比值的预后意义。
这是一项单中心回顾性分析,涵盖了707例连续的首次孤立性经导管二尖瓣缘对缘修复术后448天(四分位间距,86 - 958天)的随访。根据队列中TAPSE/PASP比值的中位数0.37 mm/mm Hg进行分层,对符合条件的病例进行全因死亡率和心力衰竭住院情况的检查。
TAPSE/PASP比值低的患者功能性二尖瓣反流的患病率更高,合并症负担更重,心脏功能的临床和超声心动图指标更差,技术成功率也更低。术后,他们在二尖瓣反流分级和功能状态方面在1个月和1年时的改善情况相似,但在所有研究时间点(1年时,分别为15.3%对7.6%、20.7%对10.2%、32.3%对16.1%)死亡、心力衰竭住院以及两者综合的发生率更高(所有P <.001)。较低的TAPSE/PASP比值与1年死亡或心力衰竭住院联合终点的较高风险独立相关(风险比,2.84;95%可信区间,1.09 - 7.43;P = 0.033)。一种新的TAPSE/PASP - MitraScore风险模型显示出比目前已验证的评分更好的鉴别性能。亚组分析仅在功能性二尖瓣反流患者(n = 383 [54.2%])中产生了同样显著的结果,当使用基线TAPSE/PASP比值的亚组特异性中位数时结果依然如此。
经导管二尖瓣缘对缘修复术前TAPSE/PASP比值低可识别出高风险患者,并预测术后预后较差。